Skip to main content

Find Clinical Trials

Home
Conditions
Soft Tissue Infections

Clinical trial condition

Soft Tissue Infections

Explore clinical trials studying Soft Tissue Infections. Study availability and eligibility vary by location and protocol.

66 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Soft Tissue Infections trial results

Completed

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

NCT02378480

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
Locations: Site 261 Mobile, Alabama, United States

Site 262 Chula Vista, California, United States

Site 254 La Mesa, California, United States

Site 258 Oceanside, California, United States

View all 78 locations

View Trial Details

Completed

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

NCT02877927

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
Locations: Site 620 Birmingham, Alabama, United States

Site 642 Mobile, Alabama, United States

Site 616 Anaheim, California, United States

Site 601 Anaheim, California, United States

View all 50 locations

View Trial Details

Completed

Skin and Soft Tissue Infection (SSTI) Study

NCT02600871

Conditions: Abscess, Infections, Inflammation, +7 more
Locations: University Hospital San Antonio, Texas, United States

View Trial Details

Completed

Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections

NCT01967225

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: Nagakute, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Toyoake, Aichi-ken, Japan

View all 46 locations

View Trial Details

Completed

Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

NCT01370616

Conditions: Bone Diseases, Bone Diseases, Infectious, Cardiovascular Diseases, +20 more
Locations: Not specified

View Trial Details

Completed

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

NCT02607618

Conditions: Infections, Skin Structures and Soft Tissue Infections, Soft Tissue Infections
Locations: California Anaheim, California, United States

California Buena Park, California, United States

California Chula Vista, California, United States

California La Palma, California, United States

View all 54 locations

View Trial Details

Completed

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

NCT02600611

Conditions: Infections, Skin Structures and Soft Tissue Infections, Soft Tissue Infections
Locations: California Buena Park, California, United States

California La Mesa, California, United States

California Long Beach, California, United States

California Modesto, California, United States

View all 56 locations

View Trial Details

Completed

Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).

NCT01790698

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Fasciitis, +8 more
Locations: Rigshospitalet Copenhagen, Denmark

University of Bergen Bergen, Norway

Sahlgrenska University Hospital Gothenburg, Sweden

Blekinge Hospital Karlskrona, Sweden

View Trial Details

Completed

The LOOP Trial in Treatment of Skin Abscesses

NCT03398746

Conditions: Abscess, Infections, Inflammation, +4 more
Locations: Not specified

View Trial Details

Completed

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT01984684

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +7 more
Locations: Melinta 303 Study Site Mobile, Alabama, United States

Melinta 303 Study Site Montgomery, Alabama, United States

Melinta 303 Study Site Anaheim, California, United States

Melinta 303 Study Site Chula Vista, California, United States

View all 94 locations

View Trial Details